Sign In
Buy PRI
$255.10
-4.92 (-1.89%)
At Close: Jun 03, 2026
Primerica Schedules Fourth Quarter 2022 Financial Results Webcast
04:30pm, Wednesday, 25'th Jan 2023
DULUTH, Ga.--( BUSINESS WIRE )--Primerica, Inc. (NYSE:PRI) announced today that it will hold a webcast on Friday, February 24, 2023, at 10:00 a.m. Eastern time to discuss the Company's results for the
Here's Why Should You Hold Primerica (PRI) Stock in Portfolio
03:43pm, Monday, 09'th Jan 2023 Zacks Investment Research
Compelling portfolio, strong market presence and solid capital position poise Primerica (PRI) well for growth.
Here's Why Should You Hold Primerica (PRI) Stock in Portfolio
12:03pm, Monday, 09'th Jan 2023
Compelling portfolio, strong market presence and solid capital position poise Primerica (PRI) well for growth.
Dividend Champion, Contender, And Challenger Highlights: Week Of December 11
05:29am, Sunday, 11'th Dec 2022 Seeking Alpha
Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see companies with upcoming ex-dividend dates and pay dates.
AXIS Capital (AXS) Okays Share Buyback, Ups Dividend by 2.3%
06:14pm, Friday, 09'th Dec 2022 Zacks Investment Research
AXIS Capital's (AXS) recent dividend hike and share buyback approval reflects its intention to enhance shareholders' value supported by its strong financial position.
Primerica: When Going Gets Tough, Simplify (Technical Analysis)
03:39am, Sunday, 27'th Nov 2022
Technical set up shows signs of a slow recovery of the uptrend. The cost of living hits middle-income families and may cause a headwind to the life insurance sector.
Primerica (PRI) OKs Share Buyback to Boost Shareholder Return
04:15pm, Monday, 21'st Nov 2022 Zacks Investment Research
Primerica's (PRI) board of directors approves $375 million to repurchase its common stock through the next year.
Primerica (PRI) OKs Share Buyback to Boost Shareholder Return
12:47pm, Monday, 21'st Nov 2022
Primerica's (PRI) board of directors approves $375 million to repurchase its common stock through the next year.
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
02:11pm, Thursday, 10'th Nov 2022 Benzinga
Upgrades
According to Stifel, the prior rating for Clearside Biomedical Inc (NASDAQ:CLSD) was changed from Hold to Buy. In the third quarter, Clearside Biomedical showed an EPS of $0.13, compared to $
Primerica, Inc. (PRI) Q3 2022 Earnings Call Transcript
03:43pm, Wednesday, 09'th Nov 2022
Primerica, Inc. (NYSE:PRI ) Q3 2022 Earnings Conference Call November 9, 2022 10:00 AM ET Company Participants Nicole Russell - Investor Relations Glenn Williams - Chief Executive Officer Alison Rand
Primerica (PRI) Beats Q3 Earnings and Revenue Estimates
11:05pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Primerica (PRI) delivered earnings and revenue surprises of 0.67% and 0.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Primerica (PRI) Beats Q3 Earnings and Revenue Estimates
07:33pm, Tuesday, 08'th Nov 2022
Primerica (PRI) delivered earnings and revenue surprises of 0.67% and 0.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Brighthouse Financial (BHF) Reports Q3 Loss, Misses Revenue Estimates
11:25pm, Monday, 07'th Nov 2022 Zacks Investment Research
Brighthouse Financial (BHF) delivered earnings and revenue surprises of -105.13% and 3.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the sto
Lincoln National (LNC) Reports Q3 Loss, Tops Revenue Estimates
09:45pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
Lincoln National (LNC) delivered earnings and revenue surprises of -630.05% and 5.85%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Primerica Schedules Third Quarter 2022 Financial Results Webcast
04:15pm, Tuesday, 25'th Oct 2022
DULUTH, Ga.
